Veterinary Medicines

Zeronil 402 mg Spot-on Solution for extra large dogs

Authorised
  • Fipronil
Download as PDF

Product identification

Medicine name:
Adimere Fipronil BF 402 mg, Spot-on oplossing voor extra grote honden
Zeronil 402 mg Spot-on Solution for extra large dogs
Active substance:
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Fipronil
    402.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 150 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 90 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 60 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 30 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 24 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 21 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 20 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 18 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 15 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 12 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 10 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 9 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 8 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 6 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 4 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 3 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 2 pipettes in individual foil sachets.
  • A 4.02ml white pipette composed of a heat-formed shell of a polypropylene/cyclicolefin copolymer/polypropylene layer and a polyethylene/ethylene vinylalcohol/polyethylene layer.A Cardboard box with 1 pipette in individual foil sachets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 109063
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0276/004
Concerned member states:
  • Bulgaria
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/06/2024
Download

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download

ie-puar-mr-iev0276004-zeronil-402-mg-spot-on-solution-for-extra-large-do-en.pdf

English (PDF)
Published on: 26/08/2024
Download